For generations, the struggles between patients and health insurers have played out in the quiet corridors of bureaucracy and the echoing halls of the courts. When a claim is denied, the journey that follows is often a weary procession: appeals, reviews, complaints, and lawsuits. Even when an insurer is found at fault, the reckoning is almost always measured in a payment here, a penalty there, and maybe a sanction filed away in some ledger. Now, a new proposal in Pennsylvania asks a question that lingers like smoke after a fire: Is that truly enough?
House Bill 2611, introduced on June 8, 2026, would carve a new path through that legal wilderness. It proposes a crime called “Aggravated Assault of an Insured,” and it would place the chief executive officer (CEO) of a health insurer in the crosshairs of criminal law if a denial of medically necessary care leads to grave injury or death.
The bill is not yet law. It sits in committee, awaiting its fate. Yet it has already raised a question that cuts to the heart of our sense of justice: when a denial of coverage leaves a patient without the care they need, and tragedy follows, should our response be limited to fines and paperwork?
Supporters of the bill answer with a resounding no. They see insurers as gatekeepers wielding immense power over the fate of the sick and vulnerable. While insurers do not write prescriptions, their decisions often decide whether a patient’s hope becomes reality or remains out of reach. When a company’s refusal blocks a doctor’s recommended care, the result can be a closed door at the very moment it matters most. If that decision brings suffering or loss, supporters insist that responsibility must fall on those at the helm.
Real physician voices, twice a week
Free, and one click to unsubscribe.
Critics, however, warn that this bill could transform the tangled disputes of medicine and insurance into matters for the criminal courts. They question whether it is just to hold a CEO criminally responsible for a single decision made somewhere deep within the machinery of a vast corporation.
Traditionally, insurance disputes have been matters of correction and compensation. A denied claim leads to a challenge, and if the insurer is found in error, the remedy is financial or regulatory. HB 2611, however, charts a different course. It would treat some denials as acts with the weight of criminal wrongdoing.
The greatest legal barrier is the question of causation. In the realm of criminal law, it is not enough to show that a decision was wrong or even reckless. Prosecutors would have to prove that the insurer’s denial directly caused the patient’s suffering or death.
Medical outcomes are rarely straightforward. A patient may already be gravely ill, and the denied treatment may have offered only a glimmer of hope. Other options may have existed. Even when care is delayed, the defense can argue that it was the relentless advance of disease, not the insurer’s decision, that brought about the final tragedy.
By placing the chief executive officer at the center, the bill draws political attention but also exposes itself to legal challenge. Health insurers are sprawling enterprises in which the decisions that shape lives are often made by claims staff, medical reviewers, or distant administrators. The CEO may set the tone and direction, but rarely does that person hold the pen that signs off on a single claim.
This distinction is important as criminal law is built on the foundation of personal culpability. Prosecutors must show intent, knowledge, recklessness, or criminal negligence. A law that punishes a CEO simply for holding the title, without proof of personal involvement, would almost certainly face a constitutional challenge.
Supporters might answer that CEOs must answer for the systems they build. If a company’s policies predictably deny care and place patients in harm’s way, then accountability, they argue, should not end with the foot soldiers. Yet courts tend to look closer, asking: What did this person know? What did they do? How did their choices shape the outcome?
Another thorny question is the meaning of “medical necessity.” For patients and their doctors, the answer often feels simple: if a physician recommends a treatment to ward off serious harm, it is necessary. Yet in the world of insurance, that certainty dissolves into argument and ambiguity.
Insurers may rely on policy language, clinical guidelines, evidence reviews, or internal criteria. A treating physician may believe a treatment is essential, while an insurer may call it experimental, excessive, unsupported, or outside the plan’s coverage. In a criminal prosecution, a jury could be asked to decide not only whether the insurer was wrong, but whether the disputed treatment was medically necessary in a way that supports criminal punishment.
This bill gives voice to a deeper frustration simmering across the country. Many patients feel that appeals drag on, lawsuits are out of reach, and regulatory penalties are little more than a slap on the wrist. HB 2611 transforms that anger into a question for the law: When a denial of care leads to suffering, is it merely a contract dispute, or is it something more?
This idea is controversial and rests on uncertain legal ground. Yet it captures a growing unease: Health insurers are not just shuffling papers. Their choices can decide whether a person receives care at the moment of greatest need.
The bill may never become law. But it has already brought a larger question to light: when powerful institutions make choices that affect life and death, who, in the end, must answer for the harm that follows?
Timothy Lesaca is a psychiatrist in private practice at New Directions Mental Health in Pittsburgh, Pennsylvania, with more than forty years of experience treating children, adolescents, and adults across outpatient, inpatient, and community mental health settings. He has published in peer-reviewed and professional venues including the Patient Experience Journal, Psychiatric Times, the Allegheny County Medical Society Bulletin, and other clinical journals, with work addressing topics such as open-access scheduling, Landau-Kleffner syndrome, physician suicide, and the dynamics of contemporary medical practice. His recent writing examines issues of identity, ethical complexity, and patient–clinician relationships in modern health care. Additional information about his clinical practice and professional work is available on his website, timothylesacamd.com. His professional profile also appears on his ResearchGate profile, where further publications and details may be found.
